Pharma And Biotech Daily: Eli Lilly Stock Drops, Biogen Exceeds Expectations, And More Updates Pharma And BioTech Daily podcast

Artwork

News Tech News Pharma and BioTech News BioTech News Pharma Biotech Genomics Artificial Intelligence

Innhold levert av Pharma and BioTech News and BioTech News. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Pharma and BioTech News and BioTech News eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Pharma and BioTech Daily « »
Pharma and Biotech Daily: Eli Lilly Stock Drops, Biogen Exceeds Expectations, and More Updates

1d ago 0:45

Del

MP3•Episoder hjem

Innhold levert av Pharma and BioTech News and BioTech News. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Pharma and BioTech News and BioTech News eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Eli Lilly experienced lower-than-expected sales for its weight loss and diabetes drugs in the third quarter, causing its stock to drop by over 13%. Biogen, on the other hand, exceeded expectations for its Alzheimer's drug Leqembi. Biomarin surpassed sales estimates for its drug Voxzogo, while Sage reported revenue growth for Zurzuvae. Biogen also signed a deal with Neomorph. Additionally, Lilly has modified the dosing of its Alzheimer's drug Kisunlan to lower brain swelling, and Novartis has secured expansion for its CML drug Scemblix. Small funds are investing in early-stage science, and there have been recent job openings in the biotech industry.

… continue reading

63 episoder

#News #Tech News #Pharma and BioTech News #BioTech News #Pharma #Biotech #Genomics #Artificial Intelligence

Artwork

Pharma and Biotech Daily: Eli Lilly Stock Drops, Biogen Exceeds Expectations, and More Updates

Pharma and BioTech Daily

published 1d ago

Del

MP3•Episoder hjem

Innhold levert av Pharma and BioTech News and BioTech News. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Pharma and BioTech News and BioTech News eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Eli Lilly experienced lower-than-expected sales for its weight loss and diabetes drugs in the third quarter, causing its stock to drop by over 13%. Biogen, on the other hand, exceeded expectations for its Alzheimer's drug Leqembi. Biomarin surpassed sales estimates for its drug Voxzogo, while Sage reported revenue growth for Zurzuvae. Biogen also signed a deal with Neomorph. Additionally, Lilly has modified the dosing of its Alzheimer's drug Kisunlan to lower brain swelling, and Novartis has secured expansion for its CML drug Scemblix. Small funds are investing in early-stage science, and there have been recent job openings in the biotech industry.

… continue reading

63 episoder

#News #Tech News #Pharma and BioTech News #BioTech News #Pharma #Biotech #Genomics #Artificial Intelligence

Alle episoder

×

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

Lytt til 500+ tema